vanilmandelic acid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McNamee, B | 1 |
Kelvin, AS | 1 |
Turnbull, MJ | 1 |
Tourian, AY | 1 |
1 trial available for vanilmandelic acid and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease; | 1972 |
1 other study available for vanilmandelic acid and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Urinary excretion of some monoamines and metabolites in Huntington's chorea.
Topics: Acetates; Adult; Aged; Catecholamines; Epinephrine; Female; Histamine; Humans; Huntington Disease; H | 1971 |